
Merck builds in cell, gene therapies with Mirus Bio deal
2024年5月23日 · Germany’s Merck KGaA has agreed to acquire Mirus Bio, a specialist in transfection reagents used in the production of cell and gene therapies (CGTs), in a deal …
High Quality Innovation: German Company Merck thrives in
2024年4月14日 · Shanghai's Municipal Government recently announced a series of measures designed to boost and enhance research and development in the city's science and tech hub. …
Considerations for Cell and Gene Therapy Programs Entering the …
Cell and gene therapy (CGT) describes a broad category of medicinal products with potential applications to prevent and treat human disease in multiple therapeutic areas. These therapies …
Pilot project allows foreign-invested businesses to boost CGT …
2024年11月20日 · German company Merck Testing said that the updated scope allows the company to localize advanced technologies in Shanghai's Free Trade Zone, engage in cutting …
Merck and Guardant expand partnership to develop cancer …
2022年9月1日 · Guardant Health has extended a partnership with Merck KGaA, Darmstadt, Germany, to aid in expediting precision oncology therapeutics development. Cell and gene …
6亿美元!默克收购Mirus Bio,提高基于病毒载体的CGT生产能力 …
2024年5月24日 · 5月22日, 德国默克宣布将以6亿美元收购Mirus Bio,提高基于病毒载体的基因治疗产品的生产能力。 该交易预计今年第三季度完成。 Mirus Bio公司成立于1995年,总部位于 …
它们在做什么?盘点CGT创新链上的64家头部机构 - Pharmcube
专注于CGT的全球化CTDMO. 药明生基是药明康德旗下专注于细胞和基因疗法的CTDMO (Contract Testing, Development and Manufacturing Organization) ,致力于加速和变革细胞和基因疗法及 …
CGT opening-up to spur China's bio-medical industry
2024年11月28日 · As China is intensifying efforts to deepen international collaboration and investment in its high-tech medical sectors, frontier areas such as cell and gene therapy (CGT) …
Overcoming barriers for global CGT adoption | pharmaphorum
2 天之前 · Learn about the challenges and strategies for overcoming barriers to the global adoption of cell and gene therapies (CGT) in this informative article.
Pilot project allows foreign-invested businesses to boost CGT ...
2024年11月25日 · German company Merck Testing said that the updated scope allows the company to localize advanced technologies in Shanghai's Free Trade Zone, engage in cutting …